Strategic partnerships Inteliquet operates at the intersection of technology and cancer clinical research, presenting a sales angle to partner with hospitals, cancer centers, and life sciences organizations to expand patient access and streamline trial enrollment.

Clinical trial enablement With a focus on trial selection, patient matching, and EMR interrogation, opportunities exist to upsell advanced data analytics, integration services, and compliance tools for oncology research networks seeking faster, more accurate enrollment.

Growth through leadership Key hires in 2020 across CFO, life sciences, and partnerships indicate a push to scale operations and deepen healthcare relationships, suggesting potential for enterprise-grade modules, governance, and financial workflows attractive to mid to large customers.

NCI collaboration Historical CRADA activity with the National Cancer Institute signals credibility and potential for co-developed tools or phased pilots, opening doors to NIH-supported deployments and broader federal research initiatives.

EMR interoperability Emphasis on EMR interrogation challenges presents a cross-sell opportunity for healthcare IT integrations, data normalization, and privacy/compliance automation to healthcare systems seeking to optimize clinical trial recruitment.